Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data

The authors conducted a comprehensive bioinformatic review of GHK-Cu gene expression data from multiple published microarray and RNA-seq datasets, including studies on aged skin fibroblasts, COPD lung tissue, and cancer cell lines treated with GHK-Cu. Gene ontology analysis and pathway mapping were applied to characterise the functional categories of regulated genes.

GHK-Cu was found to regulate a total of 4,082 human genes: 2,098 upregulated and 1,984 downregulated. Key activated categories included: wound healing and tissue repair genes (collagen types I, III, VI; fibronectin; laminin); antioxidant pathway genes (SOD1, catalase, thioredoxin); DNA repair genes (BRCA1, BRCA2, ATM); neurotrophin genes (BDNF, NGF); and anti-cancer genes (BRCA1/2, tumour suppressors). Key suppressed categories included: pro-inflammatory cytokines (IL-6, TNF-α, IL-1β); genes driving cellular senescence (p21, p16); and genes upregulated in cancer. In COPD models, GHK-Cu normalised expression of 31.6% of aberrantly expressed genes. The breadth of gene regulation is unprecedented for a tripeptide and suggests GHK-Cu acts as a master activator of the body's repair and regeneration programme.

This is a review and bioinformatic analysis rather than a prospective experimental study, so causality between GHK-Cu treatment and observed gene changes must be interpreted cautiously. The data are drawn from multiple model systems (cell lines, animal models, human biopsy) which vary in relevance to in vivo human aging. Clinical evidence for the gene expression effects in healthy humans is limited.

This paper is the primary mechanistic reference for GHK-Cu and establishes the scientific basis for its study in anti-aging, skin rejuvenation, neuroprotection, and lung repair contexts. Any researcher working with GHK-Cu should read this review to understand the breadth of its documented effects and appropriate research applications.